Please assess the completion status of the following clinical trial:

Trial Title: The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* The patients will be screened according to a modified TRUST1 Transfusion Score. This score attributes 1 point to each of the following conditions:~  * Hb level \< 13.5 g/dL~ * Weight \< 77 kg~ * Female sex~ * Age \> 65 years~ * Non elective surgery~ * Serum creatinine \> 1.36 mg/dL~ * Redo operation~ * Non isolated surgery~ * Factors are hemodilution-related factors, and will not be included. Non isolated surgery is mandatory for inclusion. Patients will be included in presence of at least 1 within the remaining 4 risk factors:~ * Age \> 65 years~ * Non elective surgery~ * Serum creatinine \> 1.36 mg/dL '8Redo operation INCLUSION CRITERIA (patients randomized)~    1. Combined cardiac operation with expected CPB duration \> 90 minutes~   2. At least one additional risk factor within the following: Age \> 65 years; Non elective surgery; Serum creatinine \> 1.36 mg/dL; Redo operation~Exclusion Criteria:~1. Age \< 18 years~2. Patients under thienopyridines~3. Known coagulopathy~4. Known autoimmune disorders~5. Participation in another RCT~6. Pregnancy~7. Emergency operation~8. Baseline HCT \< 35%~9. Baseline Antithrombin \< 80%~10. BSA \< 1.7 m2~WITHDRAWAL CRITERION:~1. Lowest HCT on CPB \< 23%~2. Transfusions during CPB~   * Patients randomized and not withdrawn will be DOSED with the investigational drugs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Saline solution (Type: PLACEBO_COMPARATOR): None
- Fibrinogen (Type: ACTIVE_COMPARATOR): None
- Prothrombin complex (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).